tPA/DNase for Complicated Parapneumonic Effusions and Empyemas.
作者信息
Maiga Amelia, Pinkerman Rhonda, Deppen Stephen A, Scruggs Jennifer, Mcguire Philip, Tarpley John L, Grogan Eric L
出版信息
Am Surg. 2017 Dec 1;83(12):1458-1459.
Abstract
摘要
相似文献
1
tPA/DNase for Complicated Parapneumonic Effusions and Empyemas.组织型纤溶酶原激活剂/脱氧核糖核酸酶用于治疗复杂性肺炎旁胸腔积液和脓胸
Am Surg. 2017 Dec 1;83(12):1458-1459.
2
Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.预测复杂类肺炎性胸腔积液/脓胸患者胸腔内注射组织型纤溶酶原激活物/脱氧核糖核酸酶治疗失败的相关因素。
Chest. 2018 Sep;154(3):550-556. doi: 10.1016/j.chest.2018.01.037. Epub 2018 Feb 6.
3
Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients.组织型纤溶酶原激活剂用于治疗小儿患者的肺炎旁胸腔积液。
Pharmacotherapy. 2014 May;34(5):521-32. doi: 10.1002/phar.1392. Epub 2014 Jan 4.
4
Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.组织型纤溶酶原激活剂与脱氧核糖核酸酶治疗腹部病变继发复杂性胸腔积液的安全性与有效性
Ann Am Thorac Soc. 2017 Mar;14(3):342-346. doi: 10.1513/AnnalsATS.201608-594BC.
5
Emerging concepts in pleural infection.胸膜感染的新观念。
Curr Opin Pulm Med. 2018 Jul;24(4):367-373. doi: 10.1097/MCP.0000000000000487.
6
Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema.胸膜内纤维蛋白溶解疗法在复杂性类肺炎性胸腔积液和脓胸治疗中作用的最新进展
Acta Med Indones. 2012 Jul;44(3):258-64.
7
Pharmacotherapy in complicated parapneumonic pleural effusions and thoracic empyema.复杂性类肺炎性胸腔积液和脓胸的药物治疗
Pulm Pharmacol Ther. 2005;18(6):381-9. doi: 10.1016/j.pupt.2004.12.001.
8
Point: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? Yes.观点：对于复杂性类肺炎性胸腔积液的治疗，是否应常规胸膜腔内给予纤溶药物？是。
Chest. 2014 Jan;145(1):14-17. doi: 10.1378/chest.13-2354.
9
Mixing It Up: Coadministration of tPA/DNase in Complicated Parapneumonic Pleural Effusions and Empyema.混合使用：组织型纤溶酶原激活剂/脱氧核糖核酸酶联合用于复杂性肺炎旁胸腔积液和脓胸
J Bronchology Interv Pulmonol. 2017 Jan;24(1):40-47. doi: 10.1097/LBR.0000000000000334.
10
Intrapleural tissue plasminogen activator for complicated pleural effusions.用于复杂性胸腔积液的胸膜内组织型纤溶酶原激活剂
J Trauma. 2004 Dec;57(6):1178-83. doi: 10.1097/01.ta.0000141879.67441.52.
引用本文的文献
1
Can intrapleural alteplase treatment be an alternative to videothoracoscopic deloculation and decortication in pleural empyema?在胸膜脓胸中，胸膜腔内注射纤溶酶治疗能否替代电视胸腔镜下松解术和剥脱术？
Wideochir Inne Tech Maloinwazyjne. 2021 Sep;16(3):580-586. doi: 10.5114/wiitm.2021.103920. Epub 2021 Feb 24.
2
Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.胸膜内纤维蛋白溶解疗法与安慰剂或不同的纤维蛋白溶解剂在治疗成人肺炎旁胸腔积液和脓胸中的比较。
Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD002312. doi: 10.1002/14651858.CD002312.pub4.
本文引用的文献
1
Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection.胸膜内组织型纤溶酶原激活剂和脱氧核糖核酸酶治疗胸膜感染
J Thorac Dis. 2015 Jun;7(6):999-1008. doi: 10.3978/j.issn.2072-1439.2015.01.30.
2
Intrapleural use of tissue plasminogen activator and DNase in pleural infection.胸腔内应用组织型纤溶酶原激活物和 DNA 酶治疗胸腔感染。
N Engl J Med. 2011 Aug 11;365(6):518-26. doi: 10.1056/NEJMoa1012740.
3
Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial.胸腔镜纤维板剥脱术与胸腔置管溶栓术治疗儿童脓胸的前瞻性随机试验
J Pediatr Surg. 2009 Jan;44(1):106-11; discussion 111. doi: 10.1016/j.jpedsurg.2008.10.018.
4
Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.胸腔内使用纤维蛋白溶解剂治疗脓胸和复杂性肺炎旁胸腔积液：一项荟萃分析。
Chest. 2006 Mar;129(3):783-90. doi: 10.1378/chest.129.3.783.
Zotero 插件